Emiin Medeelel

, ,
2008/06

2008

3-4
5-11
/ /
12-17
2008
18-21
22-28
29
30-31
32-35
36-41
42-43
44-45
46
47-50

, , ,
.

, 17

.
2008- 2009
.
-
2008 121 , 2008 11
-
, , , ,

.
2
. :
-
-
-
-
-
- ,
-
-
-
,
.

,
!

!

,
.
,

.

.
,

- , , ,
, , ,
.

- , , , ,
.

- .

-, 4- 3- Arial 12
.

. , , - (
)
. , , -
( )
. , -
. , , ,
. , , ,
. , ,
. , , , -

. , -
, ,

.

: 70128801, zuzaan@nchd.mn

-

VEN (Vital-
, Essential- ,
Nonessential-
) ,
.

,

, ,

.
-

,
, ,

,
, ,

-

,
,
,
.
,
4.2,
-

2008 05
.

,
,

, 3

,
- .

-
,

, ,
,

, ,

32 10,
13, 22,
23, ,
29, ,
30
.
95

.
1
2
25/-10
1/ (), 1
*
*
*
*
*
*
*
*
3
4
*
*
., 400/ 10
., 10/
., 5 000 , 25000 /
1
( ), 500
7
8
10,20,50/-1-5
., 5/ 2
*
*
*
*
*
*
*
*
*
*
*
*
9
10

5/-2
*
*
*
*
11
12
70
*
*
*
*
*
*
*
*
13
14
20/ 2
400
., 40 /; 80 /; 100
/ 10
. , 50/10
15
25%-1
16
17
18
*
*
*
*
*
*
*
*
*
*
19
2%-2
250/ 10
100, 200, 400
., 10 (,
)1
20
21
22
23
2.5 () 1
., 5 , 10 1
30/1
*
*
*
*
24
25
26
27
., 50 ()/ 2

30%-10
28
50.0
29
30
, 40, 10/ 1
., 25 (.)/1
,, 100 ()
31
/
/
1/ 1
, , ,

, 2002 219
81
2008 03 26- .
, , ,
, , ,
,
, .
www.moh.mn
.

,

2008 05 28- 01

.
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
, 50 20
, 100 20
, 100 30
, 200 30
, 25 50
//
10000
2000
900
12500
3500
//
5000
1000
630
6250
1750
, 500+125, 10
13000
6500
//, 250 10
1300
600
//, 500 10
1800
900
//, 250 10
850
425
//, 500 10
1500
750
, 200 10
, 400 10
, 5% 10
3500
4800
3300
1750
2400
1650
, 3% 4.5
12000
6000
, 200 , 24
, 50 30
, 0,6 20
, 25% 20
/, 5%/
200
7500
2000
2100
1500
3750
1000
1050
750
400
200
15.
16.
17.
18.
19.
20.
21.
22.
23.
24.
25.
26.
27.
28.
29.
30.
31.
32.
33.
34.
35.
36.
37.
38.
39.
40.
41.
42.
43.
44.
45.
46.
47.
48.
49.
50.
51.
52.
53.
54.
55.
56.
57.
58.
59.
60.
61.
62.
63.
64.
65.
66.
67.
68.
69.
(),
100/ 200
, , 0,1%
() 15
, 2 50
, 300 50
, 80 20
50
1% 15
, 25 10
, 25, 20
, 50 20
, 50 20
/, 125 20
, 500 30
, 10 10
, 250 30
, 25 10
/, 100 10
, 10
, 200 10
, 400 10
, 125 10
, 5 10
/ 25 25
, 60 50
, 500
, 500 30
, 200 10
, 1 30
, 500 10
, 50 30
, 1% 20
, 30 10
, 0,1% 10
, 250+25 30
, 50 2
, 150 1
, 100 6
, 50
, 500 50
, 250 10
, 0,5% -500
, 10 20
, 10 25
, 2,5 30
, 250 10
, 2
, 2% () 30
, 10 10
, 30 10
, 100
, 250 56
, 500 40
, 500 10
, 50 50
, 500000 10
/250000 /
, 50 30
, 100 30
, 10 50
, 20 30
, 50 50
, 4% 5
, 25 ()
30
3500
2450
5500
2750
2000
32000
2500
1800
1600
2000
4200
3200
3200
1600
1800
1600
1000
750
900
1500
550
950
280
500
1300
1700
200
2500
1500
1000
580
2500
2500
2700
1550
19000
2900
3000
750
5000
6800
1500
400
2500
2200
9700
300
8700
2000
800
2810
2800
18000
12000
750
700
1400
22400
1250
900
800
1000
2100
1600
1600
800
900
800
500
375
450
750
275
475
140
250
650
850
100
1250
1050
500
290
1250
1250
1890
775
13300
2030
2100
375
2500
3400
750
200
1250
1100
4850
150
4350
1000
560
1967
1400
9000
6000
375
350
2000
1000
500
1000
2200
6200
4500
1400
250
500
1100
3100
3150
700
720
360
70.
71.
72.
73.
74.
75.
76.
77.
78.
79.
80.
81.
, 1 100
, 5, 100
0,5% 15
, 10
, 40 50
, 250 20
, 25 20
, 10% 500
, 150 10
, , 200000 (110) -
50
,
10000 (5,5) 50
, 100000 /
, 5% 30
2% 20
, 4 30
(),
100/
, 35 80
, 25 20
3500
3900
1550
950
1900
1100
1000
1500
1100
1750
2730
775
475
950
550
500
750
550
2500
1250
2500
1250
2300
1150
500
500
3000
250
250
2100
3800
2660
4500
4500
2250
2250
, 400+80 10
320
160
82.
, 20-25% 10
1200
600
83.
, 500 10
15700
7850
84.
, 10 30
3000
2100
85.
, 200 20
4200
2940
, 0,5%
() 15
2700
1350
2300
1150
1200
2500
500
5400
450
650
520
900
2800
1000
600
600
1000
900
600
1250
250
2700
225
455
260
630
1960
500
300
300
500
450
, 500 50
3500
1750
10% -20
, 25 10
, 500 10 /50/
, 250 10
, 5 10
, 10 10
/, 1,25 (50000
) 20
, 250/ (10000
) 10
/, 250 10
450
18000
1800
1250
3300
5000
225
12600
1260
625
16520
2500
400
200
3000
1500
1300
650
, 30+150 21
1500
750
86.
87.
88.
89.
90.
91.
92.
93.
94.
95.
96.
97.
98.
100.
101.
102.
103.
104.
105.
106.
99.
107.
, 1% 5
()
1% 5
, 0,25% 5
, 15% 200
50, 20
, 27,9 /
, 15 6
, 250 10
, 10 25
, 5 100
, 40 10
, 250 10
, 250 10
, 1% 10
, 4 20
MNS 5260:2006
.

,
, ,
( )-
.

,
, ,

. :

, ,
, ,
, .

MNS 5260:2008

MNS 5260:2006-
MNS 5260:2008-
7.3
, ,

5.6
5.5
8.2-
8.2
8.3 8.3 20 2.5 3.5

11.3.4 ,

18.2
,
2

19.2
9

,
3 - 4

2 - 2

10
, MNS 5376:2004
.
, 6.5, 6.6, 20.2.1

, 2008 10 30-
27 , MNS 5376:2004
.

5.2

100160
6.10
6.18
7.5
7.5.7
80115

5.2.1
5.3
100160
80115

,
.
11

/ /

-

.

,
1/3-

. ,

,

.
-

50-
.

. : ,
,

.

.
:

,

.
30-90%
.

23,4%
-

1/12- .

6,1 ..
.
,
,
, ,
.
12
, - 2001

25,3%,
20,6%, 19,4%

21,76%

27,9% .
50%
/1996/, . 48,5% /,
1999 /, 43,3% /, 2000
/, ., . 21,6%

. 16
41,5%-
.

29-63%,
27-30%,
75%

48,5%
25,3%, 20,6%,
19,4% .
/2000-2001 /

. /600 /
: 45,8%

41,4%

68,5%

.
,

,

, ,

.

-
:

,
.

.

.

.
- 1999 :

,
.

.

.
, , ,

.

,
, ,
, ,

8-10
,
-
.

13
. :
, ,

,

/
7-8 /
.

,
,
,

.

,

.

.
/- /

,

.
:
,
,

.
:
,
, ,
.

:

.

,
.

.
, ,
,
//
4
.

/ /-
.

,

.
, ,
,

14
( )

( )
( )
15
, / /
.

.

,

, ,
.

.

.

//
,
, 4-6-8-12
.

/
/

, ,
, /
/ ,

.
/,
/

.

1.

2.

3. ,
.

4.

//

5.
,
,
.

3. ,
.
4.

.
5.
,
.
. :
1.
.
2.

//

,
.

:
1.
.
2.
,
. :
/
, / .
/
/
/
/

16
3.
/ : /

,
.

,
.

,

.
20-25%-

.

.

.

,
,

,
.

, ,
.
,

.

,
,

.
,

/MNS-4621-98/-
3.1.6-
, ,
3

,
,

.

.

//-

,
.

,
.

,

.
.
17

2008 1485
, 15 , 67 .

13 .
59
20%-
.

, ,
/ 1/.
1. - 2008

15
-
.
,
/ 2/.
2. 2008 //
18

12 , ,
/ 3/.
,
,
.
3. 2008 / /
2008

1.

1,
Yanzhou Xier Kangtai

Pharmaceutical Co.,Ltd
2.

250/500,

3.
SPIC, Shandong Reyoung

0,5/1, Pharmaceutical factory
4.

Harbin Pharmaceutical Group
0,5/1,
Co.,Ltd -
5.
0,5,
6.
250/500,

7.
375/625
375/625,
8.
500
500,
Aurobindo Pharma Limited

-
250/500,
T.O Chemicals LTD-
625,
GlaxoSmithKline Beecham
Pharmaceutical-
500,
Korea United
250/500
+
10.

9.
11.
12.
500
500,

-
13.
500,
NCPC-
14.
500,
NCPC-
15.
500
500,
Noble Healthcare
16.
250/500,
T.O Chemicals LTD-
19
17.
18.
5,
500 500 20,
SA Alcon-Couvreur NV
19.
1000/2000
1000/2000,
20.
1,
21.
1000,
200
200,
T.O Chemicals LTD-
23.
50/150,
Noble Healthcare
24.
150 10,
25.
T.O pharma Co.Ltd-
26.
100/500,
3,5,
3,5,
22.
27.
28.
29.
30.

-
Harbin Pharmaceutical Group
Co.,Ltd -
400,
400/250,

Bayer Healthcare AG

Bayer Healthcare AG

250/500,
31.
100,
Shijiazhuang Ouyi
32.
100
100 100,
33.
480,
NCPC-
34.
240/5,
NCPC-
35.
250,
NCPC-
36.
500
500,
PT Otto Pharmaceutical
Industries Mensa group
37.
0,5%-100,


Pharmaceutical factory

38.
500 10,
Noble Healthcare
40.
500/100,
41.
250 100,
39.
42.
43.
Shreya Life Sciences PVT

250/500 5,

1,2/2,4,

44.
1,
45.
80/2,
46.
47.
100/200-5,
250,
20




Noble Healthcare
49.

250
50.
+
51.
48.
250,
500000 ,
7,
5,
52.
750/1,5,
GlaxoSmithKline
53.
1,
54.
5,
-
PT Otto Pharmaceutical
Industries Mensa group
2000,
150/300 30
250 50,
240/5-60,
55.
56.
57.
+
58.
+
59.
150/300
250
480 100,
- .
2009.05
10.2007
Cofetol 120 ml
0.708307
2010.07
4.
80622
Yang zhou
5.
6.
7.
10%-100
160205
2010.02
8.
- 40
0.103
2011.01
Sanofi
, ,
1.
10
1257506
2.
3.
21

,

.
( )

()
(3,
10).
(antibacterial
treatment)

.

,
(5, 10).

()
,

. ,
()
,

; ,

(, ,
, - ..)
,
( , , ..)
(3, 10,
11).

,
.

200

(12).

(1,
4, 12, 17). :

,
,
,

,

,

..

5 (8, 12,
16, 17). :
1. ()

2.
3. ()

4.
5.
, 5
22
3

, ,

,

(8).
,
5
,
(3,12,14).
1-
: -,
, , ,
, , ,
, ,
, , ,
, , ,
,
(12).
,
:
,
,
, -

;
:
,
, , ,
, , ,

;
: , ,
,

.
: , -
,
,
,
,

(11, 12).

.
(4, 11, 12, 16,
17) , -
: ,
(I, II, III, IV ), ,

:
(,
,
, ,
,
,
),
(,
), II (), III
(, , )
(2). IV

.
-
,
,
.

.

.
,

. ,

,

(6, 7, 16).

90%-
-
.
-
, -
()
. ,

23

.
|,
|
(8, 9, 12).
-

,
,
,
,
(2).
-, -

.

.
()
,
()
.
(
, ,
, , ,
, ,
, ..)
(7, 16, 17).

, ,

( )
,

. 70

.
,

.

,
.

,

,
(14, 17).

, ,
.

(50 )
, ,
.
-, -

.
.
(, , , ,
,
..)
.
()
.

.
( ) .
, ,
(5, 8, 13, 14).

(12). ,

(2). 1963

.
,
.
-, - ,

.
24

, ,

. ,
-

,
, , ,

.
() .
.
.

(12, 17, 18):

- ,
-
,
-
- ,
- ,
, ..
- , , ,

.

(12).

,
,
. ,
.
-, , (,
)
.

.

(
), ,
.

( ), ,
, , , ,
,
,
. ,
, 8 ,
,
(11, 12).

- . , (,
, , , )
, H.influenzae,
B.pertussis
. V.El Tor,
N.meningitidis, N.gonorrhoeae, Brucella spp. .

, ,

. , ,

, , ,

. ,
.
,
,

(12, 14, 17).

, ,
()

25
, ()
, ,
.
3.
(,
,
)-
.
4.
(,
,
)-
,
.

.

,
. ,
, , , ,
, , 3
(11, 13,
14).

,
,
,
(2).
-,

.

.
, .
,
, ,
,

,
. ,

.
(-, ,
, , , )
.
,

, ,
-

. ,
,
,

,
(13, 14,
17).

60

(
) .

,
,
,
,
,
,
.

.
4
(11, 12):
1.
(,
, ..) - (,
, ), -
(, ),
,
.
2.
(,
, ..)26
.
(
,
,
,
..)
. ,
, , ,

,
.

, , ,
, , ,

(4, 6, 12).

(-,
-) ,

.
,
(2).

. .

. -

.
, ,
(, , )
.
,
, , -6--
, , ,
.
, , ,
,
(11, 12,
14, 17).

(5-
)-
8- ,
(, ,
) .
,
,
.

.

(16, 17).

.
5-
,
(, , ,
, )

, ,
. , , ,
,
.
, 80-100% .
, ,
. ,
(6, 9, 14).

(, ,
) , ,
,
,
- ,
, , , 12

. ,
3 ,
,

.

, ,
, , ,
27
, , ,
,
,
. (12, 14, 15, 18).
,

,

, ,

,
.
,
,
,

,

, ,
.

1. ., .
. ., 2008
2. . , 2008 11
3. . ., 2008
4. , , . . II . ., 2003
5. . .., ..,
... , , 2002
6. .., .., ..
. 2-, . . ,
2000
7. .., .. . .,
, 2001
8. .. . ., , 1998
9. . ... .,
-, 2003
10. . .., ...
., 1998
11. .., .. . ., 1982
12. .
.., ... , , 2003
13. .., .., ..
. ., , 2002
14. Antibiotic Guidelines. 7 th Edition. Australia, Melbourne, 1992
15. Goodman and Gilmans The Pharmacological Basis of Therapeutics. Seventh Edition. New York Toronto London, 1985
16. Reese R.E., Betts R.F., Gumustop B. Handbook of antibiotics. 3rd ed. Philadelphia,
Lippincott Williams & Wilkins, 2000
17. WHO Model Formulary 2002. Editors: Mary R. Couper, Dinesh K. Mehta. WHO,
Printed in the United Kingdom, 2002
-
.

www.nchd.mn

28
- 2009

1.
9-13/ II
30,0
3,0
2.
23-27/ III
30,0
3,0
3.
27/IV -1/V
30,0
3,0
4.
,
,
( )
8-12/VI
30,0
3,0
5.
6-10/
30,0
3,0
- 2009

2
3
13-17/ IV
45,0
3,0
4-8/ V
45,0
3,0
25-29/V
45,0
3,0
, (
)
15-19/VI
45,0
3,0
GMP,

2-6/I
45,0
3,0
-
29

- - , ....
,
, , , ,
/MNS/,
, , ,
,
. ,

.

. 2007 1993 16638 2008
3035 22707 .
2003-2008
,

, ,
2008 180,0
. : , ,
, ,
.

, ,
,

.
30
Varian 920-LC analytical high performance liquid chrmatograph
LAL / Limulus amebocyte lysate /
.
.
31

5
- -
.
, ,
5 5 , 10000
3 .
5
,

,
,
.
,
, ,
, , , ,
, ,
, , ,

.
,
, ,
, ,
, ,

(IUPAC report on chemical safety management 1993, 1999 ).
, 80

,
.
, , , , , ,
, , ,
,
,
(
2003, 2004, 2005, 2006, 2007 ).
2003 2007
1588 211 13.3%
, 393 24.8 % , , 213 13.4 %
, 482
30.4 % ,
.
82.6%-
4 .
32

129
61.1% , 82 38.9% ( 1) 45
21.3% 0-4 , 46 21.8% 5-15 , 26 12.3% 1619 , 71 33.7% 20-44 , 16 7.6% 45-64 , 7
3.3% 65 ( 2).

0.01 %, 10000
1.0 2003 -2007
534.2, 36.9 , 5 2 967
259.60 , 593 451.92 ( 1) .
33
()
2003
8,7
330,6
21202,36
339237,76
2004
7,6
410,4
47267,17
756274,86
2005
8,4
453,6
47224,37
755589,98
2006
5,7
183,9
42526,31
552842,00
2007
6,5
227,5
43331,92
563315,00

-
- ICD 10

, , - 3 ( 3).

,

,
,
.
20 44
0 4

.
34

(Adverse Event Reporting System-AERS),

2008 1-3

- WHO Newsletter 2008 -

.
:
/ /
Arginine Hydrochloride Injection
/ (R-Gene 10)
Desflurane (Suprane)
Duloxetine (Cymbalta)
Etravirine (Intelence)
Fluorouracil Cream (Carac) and
Ketoconazole Cream (Kuric)
Heparin
Icodextrin (Extraneal)
Insulin U-500 (Humulin R)
Ivermectin (Stromectol) and Warfarin
Lapatinib (Tykerb)
Lenalidomide (Revlimid)
Natalizumab (Tysabri)
Nitroglycerin (Nitrostat)
Oxycodone Hydrochloride Controlled
Release (Oxycontin)
Perflutren Lipid Microsphere (Definity)
Phenytoin Injection (Dilantin)
Quetiapine (Seroquel)
Telbivudine (Tyzeka)
Tumor Necrosis Factor (TNF) Blockers
/
,
.

/

, ,

/Purple Glove
Syndrome

35

,

.

.
,
,
, .
,
, ,
.

,
-
-
, -
.

, -
, ,
.

,

.
.
, .

- (,
2006 )- ,

.
, ,
,
.
36

,
.

, .
,
, ,

, ,
.
,
,
, , .

- . :
,
, ,
,
, ,
, ,
.
,
,

-
, ,
, ,
- 3

,
.
,

,
...
,
,
,
- .

, .

.
37

+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
,
.
/
.
(
.)
.
(
.)
(
.)
(
.)

(
.)
(
.)
(
.)
(
.)
(
.)
/
.
(/
.)
(
.)
(
.)
(
.)
(
.)
(
.)
(
.)
(
.)
(
.)
(
.)
(
.)
.
(
.)
(
.)
.
/
.
38
/
.
(
.)
(
.)
(
.)

.

/
.

(
.)
(
.)

+
+
+
+/
+
+
+
+
+
+
+
+
+
+
+

,
,
, , ,
,
, .

?,
( ) ? .

,
,
,
D TV-

.
39

, ,
, ,
.
.
,
.
,

.

?
?
?
?

.
,
. .
?

?
?
? . :
.
. :
,
. .
,
.

. ( .)

.

.
.
,
, ,
40
,

. ,
, ,
.
.

.
.
,

.
? .

,

.
.
.
.
.

.

,

.

. ( )
?
. !
- .
41
,
, .
2007 38
- 5

.
,
,
,
.
25 8 32%-
, 17 68%- , 7 28%-
,
.
,
2008
11 14-
.
.
,
. . ,
, . , ,
.
, - .
,
,

.
, ,

.
-
-2008 , ,

, , , , 2009

, , , ,
, , , ,
,
, ,
2008 12 5, 6-
.
42

, 2-
, , .
, ,
.
, 6
.
1.
- 30 -
- 10%-10
- ,
2. 50
-
- 5
- -52
3.
4.
5. , / /

6.
.

( - -
. .-,
., ., - .)
43

- .

, ,

.
(EMEA)
, ,

.
.
/Committee for Medicinal Products for Human Use/
,
, ,
,
, , ,

.
Reference: European Medicines Agency Presss Release, Doc. Ref. EMEA/CHMP/
382927/2008. 24 July 2008. http://www.emea.europa.eu
.

, , ,
, .

.
(EMEA)
.

.

/ Committee for Medicinal Products for Human Use
(CHMP)/ .
2008 7

,
-
.
44

.
,

.
Reference: European Medicines Agency Press Release. Doc. Ref. EMEA/380260/
2008. 24 July 2008. http:/www.emea.europa.eu
!

, ,
, , , , , , ,

.

.
, .

10

5 , 48
,
,
.
.
References 1. Rapp RP, Kuhn R. Clinical pharmaceutics and calcium ceftriaxone. Ann pharmacother 2007;41:2072. Epub 6 nov 2007. DOI10.1345/aph.1K410.
2. Gin AS, Wheateon H, Dalton B. Comments: Clinical pharmaceutics and calciumceftriaxone. Ann pharmacother 2008;42:450-51. Epub 29 January 2008. DOI 10.1345/aph.1K410a.
3. Minutes of Commission Nationale depharmacovigilance meeting, January 31,
2006. http://afssaps.sante.fr/htm/1/pharmaco/cr060101.pdf. Accessed 2008-06-23.
4. Information for healthcare professionals. September 2007. www.fda.gov/cder/drug/
InfoSheets/HCP/ceftriaxone.htm. Accessed 2008-06-23.
5. Communication from Medeffect, 31 July 2008. http://www.hc-sc.gc.ca
- .
45
1. I
(
)
2. III
(
)
3.
(
)
4.
5 -8

5. II
,
( )
6.

7.

8. (
)
9. (
)
10. III
,
( )
11. III , ATC
-J01FA10 ( )
12. (
)
13. (
)
14. (
)
5. III
,
(
)
6. ,
(150 )
7. (
)
8. (
)
9.
10. ,
I
11. I ,

12. - 30-S ,
,

13. II (
)
14. ,
(
)
1. II
( )
2.

3. (
)
4. J01CA04

: .
46
1992 -
.
, , ,
, , ,
.
-
,
.
,
,
,

, ,

.
22
, , ,

.
a.

b. 2006-2008

c. , 21 , ,
,

d. 2006-2008

47
, , II , III ,
, 21
, , , ,
, , .
/500.000
/
/600000 - /, 1
, 1 , 1 , 1, 1 ,
1 , , +
,
,
,
,
,
, , ,
, ,
22 GIS-ESRI Arc View3.2a, Microsoft Excell .
- 3 22
5.758.282,788 , 110.293.453,0
, 144.543,0
193.798,0 , 167.900.814,0
, 414.707,0

.
,

15 , 6 ,
2,3
. , , ,

, ,
, ,
6 .
, , , ,

.
, , , ,
, , , ,
, , ,
.
3 12.921,0 ,
128.370.896,0 .
2008 2006 128
. , , ,
,
. 1,5 1,7
.
48

(2006-2008 I , -)

(2006-2008 I , -)

(2006-2008 I , )
49
,
1:3, 1:1.5,
1:3 ,
,
.
,

.
,

(
38091 ), 500000 (
16.676.640 ) , ( 21923
), 1,0 ( 50.004.288 ),
600000 (
7.675.274,0 ),

-
.
50

Emiin Medeelel

Uploaded by

Document Information

Original Title

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Emiin Medeelel

Uploaded by

Copyright:

Available Formats

, ,

8.3 8.3 20 2.5 3.5

Yanzhou Xier Kangtai

Yanzhou Xier Kangtai

SPIC, Shandong Reyoung

Yanzhou Xier Kangtai

Aurobindo Pharma Limited

T.O Chemicals LTD-

Aurobindo Pharma Limited

T.O Chemicals LTD-

500 500 20,

T.O Chemicals LTD-

T.O pharma Co.Ltd-

Aurobindo Pharma Limited

SPIC, Shandong Reyoung

Shreya Life Sciences PVT

SPIC, Shandong Reyoung

(12, 17, 18):

Varian 920-LC analytical high performance liquid chrmatograph

LAL / Limulus amebocyte lysate /

You might also like